Dual-network semi-crossed chain stacked bionic cartilage magnetoelectric gel, preparation method and application thereof
By developing a dual-network semi-cross-chain stacked bionic cartilage magnetoelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroel The efficient in situ regeneration and biocompatibility of cartilage tissues provides new treatment options.
Patent Information
- Application Number
- CN202411077527.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-07
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2044-08-07
AI Technical Summary
In the existing cartilage tissue engineering, bionic cartilage scaffolds or gels need to be combined with exogenous cells or growth factors to provide repair functions, but they have disadvantages such as high cost, steady-state interference and immune repulsion, and traditional piezoelectric and magnetic In terms of repair effect, electrical materials have problems such as uncontrollable penetration, limited quantification of effect strength and biotoxicity.
Develop a bionic cartilage magnetoelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelectroelect Acid ester) and sodium alginate form a motion-driven magnetoelectric coupling cycle conversion effect, combining motion stimulation, magnetostriction and magnetoelectric coupling cycle conversion effect, simulate endogenous electromagnetic effects and promote in situ regeneration of defective cartilage.
It realizes the piezoelectric and piezomagnetic responses that can be freely stimulated and cyclically strengthened in a light force state, promotes the in-situ regeneration of clear cartilage tissue, and solves the uncontrollable penetration of electromagnetic field stimulation and the disadvantages of traditional materials. , and has good biocompatibility and mechanical bearing function, which is better than simple magnetic or piezoelectric stimulation induction.
Smart Images

Figure CN118987344A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of biomedical engineering, and in particular to a double-network semi-crossed chain stacked bionic cartilage magnetoelectric gel, a preparation method and application thereof. Background Art
[0002] Articular cartilage is an important component of functional movement due to its load-bearing, lubricating and mechanical buffering functions. However, due to its avascular nature, low cell density and slow cell matrix renewal frequency, cartilage tissue lacks the ability to repair itself. Cartilage defects caused by long-term mechanical wear or sudden injury will lead to osteoarthritis (OA). At present, clinical treatments for osteoarthritis include anti-inflammatory or analgesic drug intervention, stem cell therapy, growth factor-assisted induction and surgical replacement implantation. The above treatments have the disadvantages of limited effectiveness, little safety evidence and uncontrollable complications, making it difficult to achieve rapid and stable repair of defective cartilage.
[0003] Cartilage tissue engineering has been a research hotspot in recent years. Its ultimate goal is to select suitable materials to construct bionic cartilage scaffolds or gels. The mechanical properties, porous structure and high water content of bionic cartilage provide a suitable inductive environment and functional compensation for the repair of defective cartilage. However, the selection and application of materials are difficult for technicians in this field, which increases the difficulty of cartilage tissue engineering research. Moreover, the bionic cartilage scaffolds or gels prepared in previous cartilage tissue engineering research need to be combined with exogenous cells or growth factors to provide cartilage regeneration activity. There are disadvantages such as high cost, interference with the homeostasis of the internal environment and immune rejection, which limits the treatment and in situ regeneration and repair of defective cartilage.
[0004] The basis for studying bionic cartilage scaffolds is a deep understanding of the cartilage tissue environment. The extracellular matrix (ECM) of cartilage tissue maintains the principle of electrical neutrality. When sensing external functional stimulation, the uneven plasma flow movement in the liquid environment, the uneven charge exposure in the solid environment, and the piezoelectric response of collagen fibers cause the cartilage tissue to release variable endogenous electrical stimulation, which, combined with Faraday's law, exhibits an endogenous electromagnetic effect. It is maintained or weakened as the tissue state changes, regulating the expression of cellular behavior. On this theoretical basis, electromagnetic stimulation of defective cartilage has been proven to simulate and amplify endogenous electromagnetic effects and regulate extracellular Ca 2+ Reflux promotes the expression of COL2A1 and other proteins related to hyaline cartilage repair, thereby achieving rapid and stable repair of defective cartilage. This is expected to solve the potential drawbacks of the application of exogenous cell or growth factor-based bionic cartilage scaffolds or gels. However, electromagnetic field stimulation given in vitro is easily weakened by tissues, and there are drawbacks such as uncontrollable penetration and limited quantitative intensity of action.
[0005] Therefore, smart response materials came into being to provide functional modifications of multi-physical field response and release directly acting on the defect site for implanted bionic cartilage scaffolds. Among them, piezoelectric smart response materials have attracted widespread attention because they can sense mechanical loads and release electrical stimulation to promote the repair of defective tissues. However, although the various piezoelectric composite materials currently studied have good piezoelectric healing performance, their healing effects are limited by the inherent disadvantages of the piezoelectric model. The timeliness of the traditional simple motion stimulation piezoelectric response model may be affected by the piezoelectric coefficient of the material, the implantation site during surgery, the postoperative movement state of the experimental animal, and the intensity of the exercise load, and there is huge uncertainty. In addition, the ultrasonic stimulation piezoelectric response model proposed in recent reports also has the disadvantages of high cost, complex operation, and interference with motor function. In recent years, relevant reports on the application of piezoelectric materials in the field of cartilage tissue engineering have shown that traditional piezoelectric materials that are non-degradable or highly toxic are gradually transitioning to new piezoelectric materials that are degradable and have good biocompatibility. Among them, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) has attracted extensive attention and application due to its degradation rate matching the long-term repair cycle of defective tissue, high mechanical properties and safe degradation products. However, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) does not have the viscoelasticity that cartilage tissue engineering materials should have, and its inherent hydrophobicity and low biological activity also limit its conventional application in the field of cartilage tissue engineering.
[0006] In addition, magnetoelectric materials composed of piezoelectric materials and magnetostrictive materials can produce magnetoelectric coupling cyclic conversion effects by sensing external magnetic fields or electric fields, realize the mutual conversion of mechanical energy, electrical energy and magnetic energy, enhance the piezoelectric response strength and magnetism of the composite materials, and obtain better tissue repair effects. However, traditional magnetoelectric materials usually have certain biological toxicity and need to be modified to obtain appropriate biosafety. Moreover, traditional magnetoelectric materials need to use external electric fields or external magnetic fields as starting stimuli to activate the magnetoelectric coupling cyclic conversion effect, which has the disadvantages of high cost, complex operation, uncontrollable efficacy, and difficult to adjust the intensity of action.
[0007] In view of the above technical problems, the present invention provides a double-network semi-cross chain stacked bionic cartilage magnetoelectric gel. The bionic cartilage magnetoelectric gel has a motion-driven magnetoelectric coupling cyclic conversion effect in a three-phase solvent system, which provides a suitable physical and chemical environment and electromagnetic stimulation for the repair of defective cartilage while compensating for the functional loss of the defective cartilage. The bionic cartilage magnetoelectric gel drives the magnetoelectric coupling cyclic conversion effect through motion when sensing light force, including a motion-stimulated piezoelectric response model, a magnetostrictive piezoelectric response model and a magnetoelectric coupling cyclic conversion effect, to provide a piezoelectric response and a piezomagnetic response that can be freely excited and cyclically enhanced for inducing in situ regeneration and repair of defective cartilage. Combined with Faraday's law, it releases changing electromagnetic stimulation, simulates and amplifies endogenous electromagnetic effects, cascade-regulates the expression of genes related to defective cartilage repair, and promotes the in situ regeneration of hyaline cartilage tissue. Summary of the invention
[0008] The present invention achieves the above-mentioned purpose through the following technical scheme. The primary purpose of the present invention is to provide a double-network semi-cross chain stacked bionic cartilage magnetoelectric gel. The bionic cartilage magnetoelectric gel is prepared by adding 0.5-2 parts of superparamagnetic ferroferric oxide nanoparticles, 2-8 parts of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) and 2-8 parts of sodium alginate to 100 parts of solvent. The solvent is prepared from water: N,N-dimethylformamide: dichloromethane in a ratio of 4-6: 1-2: 2-4.
[0009] Preferably, the ratio of water:N,N-dimethylformamide:dichloromethane is 6:1:3.
[0010] Preferably, the ratio of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) to sodium alginate in the bionic cartilage magnetoelectric gel is 1:1-3.
[0011] Preferably, the ratio of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) to sodium alginate in the bionic cartilage magnetoelectric gel is 1:2-3.
[0012] Preferably, the bionic cartilage magnetoelectric gel is prepared by the following method:
[0013] S1. Prepare a solvent by mixing water, N,N-dimethylformamide and dichloromethane according to 4-6:1-2:2-4;
[0014] S2. Take the solvent prepared in step S1, add superparamagnetic ferroferric oxide nanoparticles at a ratio of 0.5-2:100, disperse uniformly by ultrasonication, and prepare a magnetic mixed solution;
[0015] S3. Adding poly (3-hydroxybutyrate-co-3-hydroxyvalerate) to the magnetic mixed solution obtained in step S2 to obtain a superparamagnetic ferrosoferric oxide nanoparticle / poly (3-hydroxybutyrate-co-3-hydroxyvalerate) composite solution, wherein the addition ratio of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) to the solvent is 2-8:100;
[0016] S4. Adding sodium alginate powder to the superparamagnetic ferroferric oxide nanoparticles / poly (3-hydroxybutyrate-co-3-hydroxyvalerate) composite solution obtained in step S3 to obtain a superparamagnetic ferroferric oxide nanoparticles / poly (3-hydroxybutyrate-co-3-hydroxyvalerate) / sodium alginate composite sol, wherein the addition ratio of sodium alginate to solvent is 2-8:100;
[0017] S5. Take the superparamagnetic iron oxide nanoparticles / poly (3-hydroxybutyrate-co-3-hydroxyvalerate) / sodium alginate composite sol prepared in step S4, draw it and spread it into a mold, soak it in a calcium chloride solution for cross-linking, and then dialyze it with deionized water to obtain a double-network semi-cross-chain stacked bionic cartilage magnetoelectric gel.
[0018] The second object of the present invention is to provide a method for preparing the double-network semi-crossed chain stacked bionic cartilage magnetoelectric gel, comprising the following steps:
[0019] S1. Prepare a solvent by mixing water, N,N-dimethylformamide and dichloromethane according to 4-6:1-2:2-4;
[0020] S2. Take the solvent prepared in step S1, add superparamagnetic ferroferric oxide nanoparticles at a ratio of 0.5-2:100, disperse uniformly by ultrasonication, and prepare a magnetic mixed solution;
[0021] S3. Adding poly (3-hydroxybutyrate-co-3-hydroxyvalerate) to the magnetic mixed solution obtained in step S2 to obtain a superparamagnetic ferrosoferric oxide nanoparticle / poly (3-hydroxybutyrate-co-3-hydroxyvalerate) composite solution, wherein the addition ratio of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) to the solvent is 2-8:100;
[0022] S4. Adding sodium alginate powder to the superparamagnetic ferroferric oxide nanoparticles / poly (3-hydroxybutyrate-co-3-hydroxyvalerate) composite solution obtained in step S3 to obtain a superparamagnetic ferroferric oxide nanoparticles / poly (3-hydroxybutyrate-co-3-hydroxyvalerate) / sodium alginate composite sol, wherein the addition ratio of sodium alginate to solvent is 2-8:100;
[0023] S5. Take the superparamagnetic iron oxide nanoparticles / poly (3-hydroxybutyrate-co-3-hydroxyvalerate) / sodium alginate composite sol prepared in step S4, draw it and spread it into a mold, soak it in a calcium chloride solution for cross-linking, and then dialyze it with deionized water to obtain a double-network semi-cross-chain stacked bionic cartilage magnetoelectric gel.
[0024] Preferably, the mass ratio of calcium chloride to deionized water in the calcium chloride solution of step S5 is 2:100.
[0025] The third objective of the present invention is to provide the application of the double-network semi-cross chain stacked bionic cartilage magnetoelectric gel in the preparation of artificial cartilage materials.
[0026] The beneficial effects of the present invention are:
[0027] (1) The present invention provides a double-network semi-cross chain stacked biomimetic cartilage magnetoelectric gel, which is prepared by mixing 100 parts of a solvent with a ratio of 4-6:1-2:2-4 of water:N,N-dimethylformamide:dichloromethane, to which 0.5-2 parts of superparamagnetic ferrosoferric oxide nanoparticles, 2-8 parts of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) and 2-8 parts of sodium alginate are added. The bionic cartilage magnetoelectric gel utilizes N,N-dimethylformamide, which is mutually soluble in deionized water and dichloromethane, to neutralize their repulsive polarities, so that the hydrophilic sodium alginate sol and the hydrophobic poly (3-hydroxybutyrate-co-3-hydroxyvalerate) piezoelectric plastic are evenly mixed, and a double network semi-cross chain stacking structure is formed by cross-linking with a calcium chloride solution, thereby obtaining a repair-promoting gel with bionic cartilage composition, structure and performance, which can effectively solve the limitations of the application of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) in cartilage tissue engineering;
[0028] (2) The bionic cartilage magnetoelectric gel prepared in the present invention is creatively endowed with a motion-driven magnetoelectric coupling cyclic conversion effect, including a motion-stimulated piezoelectric response model, a magnetostrictive piezoelectric response model, and a magnetoelectric coupling cyclic conversion effect. Under light force conditions, it provides a freely excitable and cyclically enhanced piezoelectric response and piezomagnetic response for inducing in situ regeneration and repair of defective cartilage. Combined with Faraday's law, it releases variable electromagnetic stimulation, simulates and amplifies endogenous electromagnetic effects, cascades and regulates the expression of genes related to defective cartilage repair, and promotes in situ regeneration of hyaline cartilage tissue. It can effectively solve the drawbacks of electromagnetic field stimulation given in vitro, such as being easily weakened by tissues, uncontrollable penetration, and limited quantitative intensity of action. It can also effectively solve the problem that the healing effect of traditional piezoelectric materials is limited by the inherent drawbacks of piezoelectric models, and can also effectively solve the application limitations of traditional magnetoelectric materials;
[0029] (3) The bionic cartilage magnetoelectric gel of the present invention has good biocompatibility and a functional environment of bionic cartilage, can release electromagnetic stimulation to promote cell proliferation and migration, promote chondrocyte differentiation, and provide mechanical bearing and support for the repair of defective cartilage; the generated new cartilage tissue has the characteristics of hyaline cartilage similar to normal cartilage tissue, which is better than the AFe group induced by simple magnetic stimulation and the VA group induced by simple piezoelectric stimulation;
[0030] (4) The preparation method of the bionic cartilage magnetoelectric gel described in the present invention is simple and clear, the preparation conditions are easy to meet, and it is easy to achieve mass production, which has broad market prospects in the field of cartilage tissue engineering; and the bionic cartilage magnetoelectric gel has good biocompatibility, stable piezoelectric properties, excellent piezomagnetic properties and superior magnetoelectric coupling cycle conversion ability, showing the advantages of significant healing effect, multifunctional action mode, economic efficiency, simple operation and low cost; it expands the application scope of piezoelectric materials and magnetoelectric materials in the field of defective cartilage repair, and also provides a new treatment plan for accelerating defective cartilage repair and in situ regeneration of hyaline cartilage. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] The present invention will be described in further detail below in conjunction with the accompanying drawings.
[0032] Figure 1 The VA gel of each system of the present invention is a physical picture;
[0033] Note: a. Physical picture of VA-2-2 sol; b. Physical picture of VA-4-4 sol; c. Physical picture of VA-6-6 sol; d. Physical picture of VA-8-8 sol; e. Physical picture of VA-3-6 sol; f. Physical picture of VA-2-6 sol;
[0034] Figure 2 The figures are the physical pictures of the VA gel of the present invention and the cross-sectional physical pictures of the VA gels of various systems;
[0035] Note: a. VA gel; b. Cross-section of VA-6-6 gel; c. Cross-section of VA-3-6 gel; d. Cross-section of VA-2-6 gel;
[0036] Figure 3 It is a characterization diagram of the mechanical properties of VA gels of various systems of the present invention;
[0037] Note: a. Tensile curves of VA-2-2, VA-4-4, and VA-6-6 gels in 1:1 system; b. Tensile curves of VA-6-6, VA-3-6, and VA-2-6 gels in 1:1, 1:2, and 1:3 systems; c. Compression curves of VA-2-2, VA-4-4, and VA-6-6 gels in 1:1 system; d. Compression curves of VA-6-6, VA-3-6, and VA-2-6 gels in 1:1, 1:2, and 1:3 systems; e. Compression modulus of VA-2-2, VA-4-4, and VA-6-6 gels in 1:1 system; f. Compression modulus of VA-6-6, VA-3-6, and VA-2-6 gels in 1:1, 1:2, and 1:3 systems;
[0038] Figure 4 It is a physical picture of the VAFe sol and gel of the present invention;
[0039] Figure 5 MTT test of VAFe gel with different concentrations of superparamagnetic ferroferric oxide nanoparticles of the present invention;
[0040] Figure 6 : is a microstructure characterization diagram of the VAFe gel of the present invention;
[0041] Note: ab VAFe gel surface microstructure; cd VAFe gel cross-sectional microstructure; eh VAFe gel characteristic element (C, O, Ca, Fe) distribution diagram;
[0042] Figure 7 The chemical composition and basic physical and chemical properties of the VAFe gel of the present invention are characterized in FIG.
[0043] Note: a. FTIR; b. XRD; c. porosity, water content and water loss of VAFe gel; d. water contact angle of SA, PHBV, VA and VAFe; e. flexibility of VAFe gel; f. swelling ratio of SA, VA and VAFe gel; g. tensile curves of SA, VA and VAFe gel; h. compression curves of SA, VA and VAFe gel; i. degradation rate of VAFe gel;
[0044] Figure 8 This is a detection diagram of the motion-driven magnetoelectric coupling cyclic conversion effect of the VAFe gel of the present invention;
[0045] Note: ab. Output voltage and output current of SA, AFe, VA and VAFe gels under the piezoelectric response model of biomimetic motion stimulation; cd. Output voltage and output current of SA, AFe, VA and VAFe gels under the magnetostrictive piezoelectric response model;
[0046] Fig. 9The output voltage and output current detection of the VAFe gel of the present invention under the changing force and the changing magnetic field;
[0047] Note: a. The piezoelectric response output voltage and output current released by VAFe gel when sensing a changing pressure; b. The piezoelectric response output voltage and output current released by VAFe gel when sensing a changing magnetic field;
[0048] Fig.10 hysteresis curves and magnetic saturation intensities of the VAFe gel and the AFe gel of the present invention;
[0049] Fig.11 The biocompatibility test diagram and cytological behavior regulation diagram of the VAFe gel of the present invention;
[0050] Note: a. MTT analysis of SA, AFe, VA and VAFe gels; b. Live and dead cell staining of SA, AFe, VA and VAFe gels; c. Hemolysis rate of SA, AFe, VA and VAFe gels; d. Cell scratch test of SA, AFe, VA and VAFe gels; e. Cell-level chondrogenic differentiation test of SA, AFe, VA and VAFe gels;
[0051] Fig.12 This is a diagram of the cartilage healing induction experiment of the rabbit osteochondral defect model using the VAFe gel of the present invention;
[0052] Note: ab. Gross appearance and Micro-CT scan of healing of animal models in Control, SA, AFe, VA and VAFe groups; c. ICRS macrohistological score; d. Bone volume ratio of healing tissue in animal models in Control, SA, AFe, VA and VAFe groups; e. HE staining, Alcian blue staining, safranin staining and COL2A1 staining.
[0053] Fig.13 Preparation and working principle of double network semi-cross chain stacking bionic cartilage magnetoelectric gel DETAILED DESCRIPTION
[0054] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0055] Example 1. Preparation of 1:1 poly(3-hydroxybutyrate-co-3-hydroxyvalerate) / sodium alginate composite gel
[0056] (1) Mix N,N-dimethylformamide, deionized water and dichloromethane in a volume ratio of 2:4:4 (100 ml) evenly;
[0057] (2) Weighing poly(3-hydroxybutyrate-co-3-hydroxyvalerate) powder, dissolving it in the mixed solvent obtained in step (1) to obtain a poly(3-hydroxybutyrate-co-3-hydroxyvalerate) solution, wherein the mass ratio of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) to the solvent is 2:100, 4:100, 6:100, and 8:100;
[0058] (3) weighing sodium alginate powder, dissolving it in the poly(3-hydroxybutyrate-co-3-hydroxyvalerate) solution obtained in step (2) to obtain a poly(3-hydroxybutyrate-co-3-hydroxyvalerate) / sodium alginate composite sol, wherein the mass ratio of sodium alginate to solvent is 2:100, 4:100, 6:100, and 8:100;
[0059] (4) The poly(3-hydroxybutyrate-co-3-hydroxyvalerate) / sodium alginate composite sol prepared in step (3) is filled into a mold, cross-linked and fixed with a calcium chloride solution (the mass ratio of calcium chloride to deionized water is 2:100), and finally soaked in deionized water to remove excess impurities to obtain a poly(3-hydroxybutyrate-co-3-hydroxyvalerate) / sodium alginate composite gel, which is named VA-2-2 (the mass ratio of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) to sodium alginate is 2:2), VA-4-4 (the mass ratio of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) to sodium alginate is 4:4), VA-6-6 (the mass ratio of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) to sodium alginate is 6:6), and VA-8-8 (the mass ratio of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) to sodium alginate is 8:8).
[0060] Example 2: Preparation of 1:2 system poly (3-hydroxybutyrate-co-3-hydroxyvalerate) / sodium alginate composite gel
[0061] (1) Mix N,N-dimethylformamide, deionized water and dichloromethane in a volume ratio of 1:6:3 (100 ml) and mix well;
[0062] (2) Weighing poly(3-hydroxybutyrate-co-3-hydroxyvalerate) powder, dissolving it in the mixed solvent obtained in step (1) to obtain a poly(3-hydroxybutyrate-co-3-hydroxyvalerate) solution, wherein the mass ratio of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) to the solvent is 3:100;
[0063] (3) weighing sodium alginate powder and dissolving it in the poly(3-hydroxybutyrate-co-3-hydroxyvalerate) solution obtained in step (2) to obtain a poly(3-hydroxybutyrate-co-3-hydroxyvalerate) / sodium alginate composite sol, wherein the mass ratio of sodium alginate to solvent is 6:100;
[0064] (4) Filling the poly (3-hydroxybutyrate-co-3-hydroxyvalerate) / sodium alginate composite sol prepared in step (3) into a mold, cross-linking and shaping with a calcium chloride solution (the mass ratio of calcium chloride to deionized water is 2:100), and finally soaking with deionized water to remove excess impurities to obtain a poly (3-hydroxybutyrate-co-3-hydroxyvalerate) / sodium alginate composite gel, named VA or VA-3-6.
[0065] Example 3: Preparation of 1:3 poly(3-hydroxybutyrate-co-3-hydroxyvalerate) / sodium alginate composite gel
[0066] (1) Mix N,N-dimethylformamide, deionized water and dichloromethane in a volume ratio of 2:6:2 (100 ml) evenly;
[0067] (2) Weighing poly(3-hydroxybutyrate-co-3-hydroxyvalerate) powder, dissolving it in the mixed solvent obtained in step (1) to obtain a poly(3-hydroxybutyrate-co-3-hydroxyvalerate) solution, wherein the mass ratio of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) to the solvent is 2:100;
[0068] (3) weighing sodium alginate powder and dissolving it in the poly(3-hydroxybutyrate-co-3-hydroxyvalerate) solution obtained in step (2) to obtain a poly(3-hydroxybutyrate-co-3-hydroxyvalerate) / sodium alginate composite sol, wherein the mass ratio of sodium alginate to solvent is 6:100;
[0069] (4) The poly (3-hydroxybutyrate-co-3-hydroxyvalerate) / sodium alginate composite sol prepared in step (3) is filled into a mold, cross-linked and fixed with a calcium chloride solution (the mass ratio of calcium chloride to deionized water is 2:100), and finally soaked in deionized water to remove excess impurities to obtain a poly (3-hydroxybutyrate-co-3-hydroxyvalerate) / sodium alginate composite gel, named VA-2-6.
[0070] Example 4. Preparation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) film
[0071] (1) Mix N,N-dimethylformamide and dichloromethane in a volume ratio of 1:3 (100 ml) and mix well;
[0072] (2) weighing poly(3-hydroxybutyrate-co-3-hydroxyvalerate) powder and dissolving it in the mixed solvent obtained in step (1) to obtain a poly(3-hydroxybutyrate-co-3-hydroxyvalerate) solution, wherein the mass ratio of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) to the solvent is 3:100;
[0073] (3) Filling the poly(3-hydroxybutyrate-co-3-hydroxyvalerate) solution obtained in step (2) into a mold, and drying in an oven at 60° C. until dry, to obtain a poly(3-hydroxybutyrate-co-3-hydroxyvalerate) film, named PHBV.
[0074] Example 5. Preparation of sodium alginate gel
[0075] (1) Mix N,N-dimethylformamide and deionized water in a volume ratio of 1:6 (100 ml) evenly;
[0076] (2) weighing sodium alginate powder and dissolving it in the mixed solvent obtained in step (1) to obtain a sodium alginate sol, wherein the mass ratio of sodium alginate to solvent is 6:100;
[0077] (3) The sodium alginate sol prepared in step (2) is filled into a mold, cross-linked and fixed with a calcium chloride solution (the mass ratio of calcium chloride to deionized water is 2:100), and finally soaked in deionized water to remove excess impurities to obtain a sodium alginate gel, named SA.
[0078] Example 6. Preparation of superparamagnetic ferroferric oxide nanoparticles / poly (3-hydroxybutyrate-co-3-hydroxyvalerate) / sodium alginate composite gel
[0079] (1) Mix N,N-dimethylformamide, deionized water and dichloromethane in a volume ratio of 1:6:3 (100 ml) and mix well;
[0080] (2) weighing superparamagnetic ferroferric oxide nanoparticles and adding them to the mixed solvent obtained in step (1), and ultrasonically dispersing them until they are uniform to obtain a magnetic mixed solution, wherein the mass ratio of the superparamagnetic ferroferric oxide nanoparticles to the solvent is 0.5:100, 1:100, 1.5:100, and 2:100, respectively;
[0081] (3) Weighing poly (3-hydroxybutyrate-co-3-hydroxyvalerate) powder, dissolving it in the magnetic mixed solution obtained in step (2) to obtain a superparamagnetic ferrosoferric oxide nanoparticle / poly (3-hydroxybutyrate-co-3-hydroxyvalerate) composite solution, wherein the mass ratio of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) to solvent is 3:100;
[0082] (4) weighing sodium alginate powder, dissolving it in the superparamagnetic ferroferric oxide nanoparticles / poly (3-hydroxybutyrate-co-3-hydroxyvalerate) composite solution obtained in step (3) to obtain a superparamagnetic ferroferric oxide nanoparticles / poly (3-hydroxybutyrate-co-3-hydroxyvalerate) / sodium alginate composite sol, wherein the mass ratio of sodium alginate to solvent is 6:100;
[0083] (5) The superparamagnetic ferroferric oxide nanoparticles / poly (3-hydroxybutyrate-co-3-hydroxyvalerate) / sodium alginate composite sol prepared in step (4) is filled into a mold, cross-linked and fixed with a calcium chloride solution (the mass ratio of calcium chloride to deionized water is 2:100), and finally soaked in deionized water to remove excess impurities to obtain superparamagnetic ferroferric oxide nanoparticles / poly (3-hydroxybutyrate-co-3-hydroxyvalerate) / sodium alginate composite gels, named VAFe-0.5, VAFe-1.0, VAFe-1.5 (or VAFe), and VAFe-2.0, and the mass fraction ratios of superparamagnetic ferroferric oxide nanoparticles are 0.5:100, 1:100, 1.5:100, and 2:100, respectively.
[0084] Example 7. Preparation of superparamagnetic ferroferric oxide nanoparticles / sodium alginate composite gel
[0085] (1) Mix N,N-dimethylformamide and deionized water in a volume ratio of 1:6 (100 ml) evenly;
[0086] (2) weighing superparamagnetic ferroferric oxide nanoparticles and adding them to the mixed solvent obtained in step (1), and ultrasonically dispersing them until they are uniform, to obtain a magnetic mixed solution, wherein the mass ratio of superparamagnetic ferroferric oxide nanoparticles to solvent is 1.5:100;
[0087] (3) weighing sodium alginate powder and dissolving it in the magnetic mixed solution obtained in step (2) to obtain a superparamagnetic ferroferric oxide nanoparticle / sodium alginate composite sol, wherein the mass ratio of sodium alginate to solvent is 6:100;
[0088] (4) The superparamagnetic ferroferric oxide nanoparticle / sodium alginate composite sol prepared in step (3) is filled into a mold, cross-linked and fixed with a calcium chloride solution (the mass ratio of calcium chloride to deionized water is 2:100), and finally soaked in deionized water to remove excess impurities to obtain a superparamagnetic ferroferric oxide nanoparticle / sodium alginate composite gel, named AFe.
[0089] Figure 1In the 1:1 system, we dissolved poly(3-hydroxybutyrate-co-3-hydroxyvalerate) and sodium alginate successively. As the concentrations of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) and sodium alginate increased, the liquid-like behavior of VA sol gradually weakened, and the mechanical structure gradually improved, showing stable solid-like properties. 2+ After solution cross-linking, VA gel exhibits a structurally stable viscoelastic behavior, providing a possibility for repairing the mechanical barrier function of defective cartilage ( Figure 2 a). However, when the concentration of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) and sodium alginate increased to 8wt%, the solubility reached saturation. Insoluble flakes with polar repulsion began to appear in the composite sol, losing its stable mechanical structure ( Figure 1 d). Therefore, 6wt% was set as the maximum concentration of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) and sodium alginate in the 1:1 system. However, due to the low boiling point of dichloromethane, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) is easy to volatilize and precipitate, resulting in a rough surface of the VA gel ( Figure 2 b) This does not conform to the surface smoothness that bionic cartilage magnetoelectric gel should have.
[0090] Therefore, on the basis of fixing the sodium alginate concentration at 6 wt% to maintain the viscoelastic structure, the poly(3-hydroxybutyrate-co-3-hydroxyvalerate) concentration was reduced to 3 wt% and 2 wt%, and 1:2 and 1:3 systems were prepared ( Figure 1 ef). Figure 2 As shown in Figures cd, as the concentration of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) decreases, the surface of VA-3-6 gel becomes smooth and delicate. Although the surface roughness of VA-2-6 gel is improved, a gel agglomerate structure appears. Therefore, from the perspective of surface structure, VA-3-6 in the 1:2 system is better.
[0091] Embodiment 8,
[0092] This experiment uses the different systems of VA gel in Examples 1, 2, and 3 as the implementation object for the following experiments:
[0093] The mechanical properties of VA gel samples of different systems were tested using a universal materials testing machine (DY35-2T, France, strain rate of 5 mm / min at room temperature).
[0094] like Figure 3 a, The tensile properties of VA gels in the 1:1 system are generally poor (VA-2-2, VA-4-4, VA-6-6). In contrast, the tensile properties of VA-3-6 and VA-2-6 gels have improved ( Figure 3b). However, due to the slightly lower poly(3-hydroxybutyrate-co-3-hydroxyvalerate) concentration of VA-2-6 gel, its soft-hard combination synergy is relatively small, and its tensile properties are slightly worse than VA-3-6. In addition, with the increase of sodium alginate and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) concentration, the compressive strength and compression modulus of VA gel gradually increase ( Figure 3 c). The compression moduli of VA-4-4 (about 0.227MPa), VA-6-6 (about 0.498MPa) and VA-3-6 (about 0.229MPa) are all within the range of the compression modulus of normal articular cartilage (0.2-0.85MPa) ( Figure 3 ef). However, due to the slightly lower concentration of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) in VA-2-6, the synergistic effect of the soft-hard combination is relatively small, and the compression performance fails to reach the compression modulus range of normal articular cartilage ( Figure 3 df). Therefore, combining mechanical properties and surface structure, the VA-3-6 of 1:2 system is determined to be the best. On the basis of fixing the concentration of each component of VA-3-6 gel, composite superparamagnetic ferroferric oxide nanoparticles are used to prepare VAFe gel with uniform composition, stable mechanical structure and smooth and delicate surface ( Figure 4 ).
[0095] Embodiment 9,
[0096] This experiment uses VAFe-0.5, VAFe-1.0, VAFe-1.5, and VAFe-2.0 in Example 6 as implementation objects for the following experiments:
[0097] Prepare several groups of gel samples of similar size in advance. Thoroughly sterilize the samples by soaking in (75% v / v) ethanol and irradiating with ultraviolet light (UV). Collect the extracted and cultured bone marrow mesenchymal stem cells (BMSCs) by trypsin digestion. Centrifuge and resuspend, and count the single cell suspension prepared by a hemocytometer. Use 24-well plates to perform MTT assays for 1, 3, 5, and 7 days. Add 1×10 4 cells and co-cultured with the sample. After a fixed number of days of culture, add an appropriate amount of MTT reagent and incubate at 37°C for 4 hours. Discard the supernatant and add dimethyl sulfoxide to dissolve the purple formazan crystals. Oscillate the well plate on a shaker for 15 minutes at room temperature to dissolve the crystals evenly. Then transfer the liquid in the 24-well plate to a 96-well plate. Measure the absorbance value at OD = 490nm using an enzyme reader. Perform three parallel tests in each group and take the average value.
[0098] It is known that the magnetic induction of the composite gel gradually increases with the increase of the concentration of superparamagnetic ferroferric oxide nanoparticles. The optimal concentration of superparamagnetic ferroferric oxide nanoparticles was determined by MTT test. BMSCs with self-renewal and multidirectional differentiation ability were selected for cell experiments and co-cultured with each group of gel samples. With the increase of the concentration of superparamagnetic ferroferric oxide nanoparticles, the cell compatibility of VAFe gel first increased and then decreased. Finally, VAFe-1.5 (superparamagnetic ferroferric oxide nanoparticle concentration of 1.5wt%) was determined to have the best biocompatibility ( Figure 5 In subsequent experiments, the concentration of superparamagnetic ferroferric oxide nanoparticles was fixed at 1.5 wt % to prepare VAFe and AFe sol and gel.
[0099] Embodiment 10
[0100] This experiment uses SA, PHBV, VA, and VAFe in Examples 2, 4, 5, and 6 as implementation objects for the following experiments:
[0101] The morphology of VAFe gel was characterized by scanning electron microscopy (SEM, Hitachi S-4800, Japan). The element distribution of VAFe gel was determined by energy dispersive spectrometer (EDS, X-MaxN, UK, 20 kV, temperature 25 ° C, humidity 39%). The crystal structure of the sample was characterized by X-ray diffractometer (XRD, Rigaku D / Max-2400, Germany, using Cu-Ka radiation, voltage 35 kV). Fourier transform infrared spectroscopy was measured using potassium bromide pellet technology and a Thermo Nicolet Nexus FTIR670 spectrometer (FTIR, IFS66V / S, Germany). The contact angle of water on the surface of VAFe gel was measured using a contact angle meter (DSA100, KRUSS, Germany, using 1 drop of 5 μL of water and a residence time of 20 s). The mechanical properties of each gel sample were tested using a universal material testing machine (DY35-2T, France, with a strain rate of 5 mm / min at room temperature).
[0102] Weigh the initial weight of several SA, VA and VAFe composite rectangular gel blocks of similar size and regular shape, immerse them in PBS buffer for a period of time, take them out, wipe off the surface moisture and weigh them, and calculate the swelling rate of the composite gel until the swelling equilibrium is reached.
[0103] The initial weight of several VAFe composite rectangular gel blocks of similar size and regularity was weighed, and the blocks were weighed again after freeze-drying to measure the water content of the VAFe composite gel.
[0104] Select several VAFe composite rectangular gel blocks of similar size and regular shape. Measure the initial weight and volume after freeze-drying. Soak them in anhydrous ethanol until swelling equilibrium is reached. Record the weight after swelling equilibrium to calculate the porosity.
[0105] Select several VAFe composite rectangular gel blocks of similar size and regular shape. Use filter paper to wipe off the surface moisture and weigh the initial weight. Then fill them into centrifuge tubes and place filter paper of the same size. After ultracentrifugation at 5000rpm for 3 minutes, weigh the remaining weight to calculate the water loss.
[0106] Select several VAFe composite rectangular gel blocks of similar size and regular shape. Weigh the initial weight after freeze-drying. Soak them in PBS buffer and incubate them in a shaker at 37°C. After a fixed time, freeze-dry the samples and weigh the current weight to calculate the in vitro degradation rate.
[0107] like Figure 6 ad, the surface and cross-section of VAFe gel are rich in micron-sized pores of varying sizes, which can provide sufficient initial aggregation space for cell adhesion and proliferation and cell matrix formation. The pore size on the surface of the gel is relatively small, giving the gel a smooth surface. The pore size on the cross-section of the gel is relatively large, which can provide suitable initial accumulation space for cells and active substances for the regeneration of defective cartilage. The gel network is staggered and stacked, giving it mechanical sensitivity and providing a structural basis for the construction of a piezoelectric response model.
[0108] The elemental composition of VAFe gel was characterized by EDS. Figure 6 eh, the characteristic elements C, O, Ca, and Fe of sodium alginate, poly (3-hydroxybutyrate-co-3-hydroxyvalerate) and superparamagnetic ferroferric oxide nanoparticles are evenly distributed in the VAFe gel structure, proving that the composition of VAFe gel in the three-phase solvent system is uniform and pure. The interweaving and stacking of various elements also provides evidence for the construction of a double network chain stacking structure.
[0109] The molecular interactions and crystal structures of each gel sample were analyzed by FTIR and XRD. Figure 7 ab, the characteristic functional groups and characteristic crystal phase structures of each component in the VAFe gel are present, and no new peaks appear, indicating that the composition of the composite gel is pure and no chemical reaction occurs. In addition, the bionic cartilage magnetoelectric gel needs to have physical properties similar to those of the cartilage extracellular matrix to provide a simulated in vivo environment for the expression of cellular behavior for repair of defective cartilage. The porosity of the VAFe gel is about 60.75% ( Figure 7 c), providing sufficient initial aggregation space for cell adhesion, proliferation and cell matrix formation. The water content of VAFe gel is about 79.73% ( Figure 7c), which is similar to the water content of cartilage tissue (60-85%), can provide appropriate hydrostatic pressure during exercise and play a mechanical bearing role. After high-speed centrifugation, the water loss of VAFe gel is only about 15.45% ( Figure 7 c). This indicates that VAFe gel has a certain lubrication potential while showing mechanical buffering effect. However, poly (3-hydroxybutyrate-co-3-hydroxyvalerate) has inherent hydrophobicity. This limits its clinical application. The introduction of sodium alginate and superparamagnetic ferroferric oxide nanoparticles just solves this problem. Figure 7 d, the water contact angle of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) decreased from 93.80±1.64° to 38.67±2.04°, which provided VAFe gel with suitable cell adhesion polarity. Figure 7 e, VAFe gel can be curled and folded at will, and can bear a weight of 2.41 kg, showing good flexibility and bending resistance. In addition, the inherent hydrophobicity of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) also reduces the swelling performance of SA hydrogel. The addition of superparamagnetic ferroferric oxide nanoparticles makes the structure of VAFe gel more compact by enhancing the intermolecular hydrogen bonding within the chain of the composite gel, and further reduces the swelling performance ( Figure 7 f). Appropriate swelling properties can provide positive surrounding squeezing force to the implanted part without interfering with the repair of defective cartilage, and replenish water content when water is lost under stress, thus demonstrating cyclic stress bearing and swelling piezoelectric response.
[0110] The tensile and compressive properties of the samples were tested using a universal material testing machine. The addition of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) made the tensile and compressive properties of VA gel better than those of SA gel. The addition of superparamagnetic ferroferric oxide nanoparticles also further improved the tensile and compressive properties of VAFe gel ( Figure 7 gh), which is consistent with the change in swelling properties ( Figure 7 f). Therefore, from a mechanical point of view, the mechanical properties of VAFe are better than those of SA and VA, and are the best, meeting the application requirements of bionic cartilage gel. In addition, as time goes by, the mass of VAFe gel slowly decreases, and it has long-term degradation ability, providing a structural basis for the long-term repair of defective cartilage ( Figure 7 i).
[0111] Embodiment 11,
[0112] This experiment uses SA, AFe, VA, and VAFe in Examples 2, 5, 6, and 7 as implementation objects for the following experiments:
[0113] It was packaged with high-purity copper foil and copper wire. It was then connected to a highly sensitive multimeter to measure and record the effective output current and voltage data. A universal material testing machine was used to set the program-controlled mode to provide different instantaneous impact forces to the gel to build a motion-stimulated piezoelectric response model. In addition, 10 small magnets of 280 mT were stacked and placed on one side of the packaged gel, and the distance was adjusted to generate magnetostriction by magnetizing superparamagnetic ferroferric oxide nanoparticles to build a magnetostrictive piezoelectric response model.
[0114] AFe and VAFe gel samples were freeze-dried and ground into powder. 1 g of gel powder was weighed and loaded into the sample tank. The hysteresis curve and magnetic saturation intensity of the gel sample were characterized by a vibrating sample magnetometer (VAM, VersaLab, USA). The temperature was controlled to room temperature. The step size was set to 400 Oe. The applied continuous magnetic field range was -3T-3T. The data was recorded and analyzed.
[0115] Figure 8 abFirst, the feasibility of the piezoelectric response model was characterized by a high-precision multimeter. SA gel and AFe gel without piezoelectric effect were used as the control group. The single impact force was set to 30N using a universal material testing machine to simulate the average joint force of New Zealand white rabbits during normal movement. Both VA gel and VAFe gel showed good piezoelectric properties when bearing impact force, and the output voltage (about ±175mv) and output current (about ±2.1μA) of VAFe gel were greater than those of VA gel (about ±150mv and about ±1.8μA). In addition, a gradient impact force was set, and the test results showed that the piezoelectric response intensity of VAFe gel changed with the impact force ( Fig. 9 a), suggesting that VAFe gel can generate a changing electric field in the complex motion force environment of New Zealand white rabbits, which, combined with Faraday's law, manifests as a changing electromagnetic field, providing the possibility of magnetoelectric conversion of electromagnetically magnetized superparamagnetic Fe3O4 nanoparticles for the magnetoelectric coupling cyclic conversion effect. In order to verify the feasibility of the magnetostrictive piezoelectric response model, as shown in Fig. 9 b, Changing the distance between the magnet and the gel sample, the results show that the magnetic field distance is positively correlated with the piezoelectric response intensity of the gel sample. Figure 8 cd, when the distance between the fixed magnetic field and the gel sample is 1 cm, the output voltage and output current values of the VAFe gel fluctuate stably within a small range, with average values of about 20.34 mV and about 0.25 μA, respectively.
[0116] In order to verify the feasibility of electromagnetic conversion, the hysteresis curve and magnetic saturation intensity of the gel sample were characterized by a vibrating sample magnetometer. Fig.10, the magnetic saturation intensity of VAFe gel is greater than that of AFe gel compounded with superparamagnetic ferroferric oxide nanoparticles of the same concentration. This shows that the magnetostrictive piezoelectric electromagnetic stimulation generated by superparamagnetic ferroferric oxide nanoparticles in a magnetic field enhances the magnetic induction intensity of VAFe gel through the magnetoelectric coupling cyclic conversion effect, and verifies the feasibility of the magnetoelectric coupling cyclic conversion effect and the possibility of electromagnetic conversion from the magnetic response level. In summary, VAFe gel releases enhanced piezoelectric electromagnetic stimulation and piezomagnetic stimulation through the magnetoelectric coupling cyclic conversion effect under motion drive, showing great potential for inducing rapid and stable repair of defective cartilage.
[0117] Embodiment 12
[0118] This experiment uses SA, AFe, VA, and VAFe in Examples 2, 5, 6, and 7 as implementation objects for the following experiments:
[0119] Prepare several groups of gel samples of similar size in advance. Thoroughly sterilize the samples by soaking in (75% v / v) ethanol and irradiating with ultraviolet light (UV). Collect the extracted and cultured bone marrow mesenchymal stem cells (BMSCs) by trypsin digestion. Centrifuge and resuspend, and count the single cell suspension prepared by a hemocytometer. Use 24-well plates to perform MTT assays for 1, 3, 5, and 7 days. Add 1×10 4 cells and co-cultured with the sample. After a fixed number of days of culture, add an appropriate amount of MTT reagent and incubate at 37°C for 4 hours. Discard the supernatant and add dimethyl sulfoxide to dissolve the purple formazan crystals. Oscillate the well plate on a shaker for 15 minutes at room temperature to dissolve the crystals evenly. Then transfer the liquid in the 24-well plate to a 96-well plate. Measure the absorbance value at OD = 490nm using an enzyme reader. Perform three parallel tests in each group and take the average value.
[0120] The steps of cell culture and material sterilization are the same as above. 1×10 4 cells and co-cultured with the material for 1, 3, and 7 days. Then discard the supernatant and wash with PBS buffer. Use Calcein-AM / PI live and dead cell double staining detection kit and place in a 37°C incubator for staining for 0.5h. Aspirate the staining solution to terminate the incubation. Add an appropriate amount of PBS buffer to each well to cover the cells. Then observe the live cells (yellow-green fluorescence) and dead cells (red fluorescence) with an inverted fluorescence microscope and take pictures.
[0121] Take an appropriate amount of healthy rabbit whole blood, add 3.8wt% sodium citrate anticoagulant, and dilute with normal saline at a volume ratio of 4:5 for later use. Place the sample in 10ml of normal saline and incubate at 37°C for 30min. Then add 0.2ml of diluted blood and incubate for 1h. Normal saline and deionized water serve as negative and positive control groups, respectively. Centrifuge all test tubes at 1000rpm for 5min. Transfer the supernatant to a 96-well plate. Read the absorbance (optical density, OD) at a wavelength of 545nm using an enzyme reader to calculate the hemolysis rate.
[0122] like Fig.11 a shows that BMSCs with self-renewal and multidirectional differentiation ability were selected for cell experiments and co-cultured with each group of gel samples. The MTT test data of SA, AFe, VA and VAFe gels were all greater than 90%, showing good cell compatibility. In addition, live and dead cell staining further characterized that each gel sample group had good biocompatibility ( Fig.11 b) The results showed that no red fluorescent spots representing dead cells were observed in the fluorescence staining image after the red and green channels were merged, and the number of green fluorescent spots representing living cells was positively correlated with the co-culture time, which was consistent with the results of the cell proliferation experiment. In order to further verify the biocompatibility of each gel sample group, Fig.11 c. The hemolysis rate of each gel sample group was less than 5%, meeting the requirements of international standards and demonstrating good biosafety.
[0123] Embodiment 13
[0124] This experiment uses SA, AFe, VA, and VAFe in Examples 2, 5, 6, and 7 as implementation objects for the following experiments:
[0125] A built-in chamber matching the cell culture plate was made, and different groups of gel samples were placed in it. The bottom of the built-in chamber was covered with uniform pore structures to facilitate the entry of the culture medium and the conduction of electrical stimulation. A horizontal shaker (NMYC-100, China) was set to a speed of 20 and shaken for 15 minutes every day to build a piezoelectric response model. The friction impact force between the gel sample and the water flow was sensed to release the changing piezoelectric stimulation for subsequent cell experiments.
[0126] The steps of cell culture and material disinfection are the same as above. Use a six-well plate to inoculate cells. Place each group of samples in the built-in chamber. After the cell fusion rate reaches 90%, use a 20μl pipette tip to mark the cell-free area. Add PBS buffer for washing. Then replace it with serum-free basal medium to eliminate the influence of serum. At 0h and 48h, after crystal violet staining, an upright fluorescence microscope (Nikon-ECLIPSE 80i / DS-Ri2 / NIS-ElementsD, Nikon, Japan) was used to observe the healing of the scratches and take pictures.
[0127] ITS (C0343, Biyuntian, China, 1%), L-proline (P120032, Aladdin, China, 0.4mmol / L), 2-phosphoascorbic acid (8855609, Aladdin, China, 91.5μg / ml), dexamethasone (D137736, Aladdin, China, 100nmol / ml), non-essential amino acids (N1250, Solebao, China, 0.1mmol / L), TGF-β3 (P02149, Solebao, China, 10ng / ml) and DMEM were used to prepare the chondrogenic induction medium. The medium was wrapped in tin foil and stored in the dark. The cell culture and material disinfection steps were the same as above. In order to avoid floating of cells after fusion during long-term culture, we coated the bottom of the 12-well plate with gelatin (C0136, Bryotime, China). After the culture dish was dried, it was washed with PBS. 5×10 4 cells. The culture medium was changed every 24 h. On the 14th day, the cells were fixed with 4% paraformaldehyde solution. Alcian blue stain (C0155S, Beyotime, China) was used for staining, and the cells were left to stand at room temperature for 1 h and washed with PBS. They were then observed under an inverted laser confocal microscope and photographed.
[0128] like Fig.11 d. The cell proliferation and migration rates of the AFe, VA and VAFe groups were faster than those of the control group, and the VAFe group had the fastest rate. The cell scratch wounds were almost completely healed after 48 hours. This shows that both electricity and magnetism alone can promote cell proliferation and migration, and also implies that the electromagnetic stimulation released by the magneto-electric coupling cyclic conversion effect has a stronger promoting effect. In addition, in order to verify that the electromagnetic stimulation generated by the VAFe gel has the potential to regulate the differentiation of BMSCs into chondrocytes, we co-cultured BMSCs with each group of gel samples in chondrogenic induction medium for 14 days, and then stained the cells of each group with Alcian blue. The results showed that the staining depth of the AFe, VA and VAFe groups was greater than that of the control group, and the staining depth of the VAFe group was the deepest, indicating that the VAFe gel has the strongest ability to promote chondrogenic differentiation ( Fig.11 e).
[0129] Embodiment 14
[0130] This experiment uses SA, AFe, VA, and VAFe in Examples 2, 5, 6, and 7 as implementation objects for the following experiments:
[0131] With the approval of the Animal Ethics Committee, several healthy New Zealand white rabbits (male, about 2.5 kg) were selected and randomly divided into five groups for in vivo experiments. After strict analgesia, anesthesia and disinfection, the knee joint was exposed through the lateral incision of the parapatellar joint and the patella was displaced. An osteochondral defect with a diameter of 5 mm and a depth of 4 mm was drilled in the femoral trochlear groove. Several gel samples of similar size in each group were strictly disinfected and sterilized and filled into the defect. The patella was reset and the joint was sutured. After strict disinfection, analgesia and injection of antibiotics, the rabbits were put back into the marked cage. Named as Control group, SA group, AFe group, VA group and VAFe group. Close observation. After 6 or 12 weeks of feeding, the rabbit knee joint tissues were collected and fixed with 4% paraformaldehyde buffer. The healing of the knee joint tissues in each group was scored using the ICRS macroscopic evaluation table. Subsequently, Micro-CT scanning (80 kV, 100 uA) was performed on the knee joint tissues in each group. The single exposure time was 50ms, the scanning resolution was 25mm, and the scanning angle interval was 0.5°. HiscanReconstruct software was used for three-dimensional geometric reconstruction and calculation and analysis of the volume of new bone formation. In addition, the rabbit knee joint tissues collected after 6 or 12 weeks of feeding were fixed with 4% paraformaldehyde buffer. After decalcification, gradient dehydration, paraffin embedding and sectioning, HE staining, Alcian blue staining, safranin staining and immunohistochemical staining (COL2A1) were performed. The defect tissue healing status was observed under an optical microscope and analyzed and evaluated.
[0132] Fig.12 a shows that in order to further verify the ability of VAFe gel to induce in situ healing of defective cartilage in vivo, we constructed an osteochondral defect model (5mm in diameter, 4mm in depth) that exceeded the critical autologous repair size. We chose the trochlear groove of the rabbit knee joint to construct the osteochondral defect model instead of the femoral head. The purpose is to reduce the postoperative discomfort of experimental animals, provide appropriate movement stimulation for the implanted gel samples, and maximize its effect on the basis of stimulating the movement-driven magnetoelectric coupling cycle conversion effect. After 6-12 weeks of treatment, in comparison, the new tissue in the VAFe group had good fusion with the surrounding tissue, and no granulation tissue similar to the Control group and the SA group appeared, and the defective cartilage healed best. After 12 weeks, the surface of the new tissue was smooth, and the color and morphology were close to those of the surrounding normal tissue. The healing of the VA group and the AFe group was second. The ICRS macroscopic tissue score also further verified this conclusion ( Fig.12c). Micro-CT reconstruction images and bone volume ratio analysis data showed that the amount of subchondral bone healing in the VAFe group was higher than that in the other groups, which could provide mechanical bearing and support for the repair of cartilage defects ( Fig.12 b and Fig.12 d). For histological and immunohistochemical evaluations, we performed hematoxylin and eosin (H&E), safranin, Alcian blue, and COL2A1 staining on the new articular cartilage tissues ( Fig.12 e). The results showed that at week 6, a large amount of newly formed cartilage tissue was gathered in the VAFe group, and its cell distribution, density and morphology were good. At week 12, the newly formed cartilage tissue in the VAFe group was well integrated with the surrounding normal tissue, showing histological characteristics similar to those of hyaline cartilage tissue. The cartilage healing of the VA group and the AFe group was second, but there was still a certain degree of cartilage tissue defect. Relatively speaking, the cartilage tissue healing of the Control group and the SA group was poor, and there were still large cartilage tissue defects and granulation tissue at week 12. In addition, strong Safranin-O staining, Alcian blue staining and COL2A1 staining were observed in the newly formed cartilage tissue of the VAFe group, indicating that under the induction of electromagnetic stimulation released by the motion-driven magnetoelectric coupling cyclic conversion effect, the newly formed cartilage tissue of the VAFe group had hyaline cartilage characteristics similar to those of normal cartilage tissue, which was better than the AFe group induced by pure magnetic stimulation and the VA group induced by pure piezoelectric stimulation. This may be attributed to the release of enhanced piezoelectric electromagnetic stimulation and piezoelectric magnetic stimulation by the motion-driven magnetoelectric coupling cyclic conversion effect, such as Fig.13 shown.
[0133] In summary, the present invention provides a double-network semi-cross chain stacked biomimetic cartilage magnetoelectric gel. The biomimetic cartilage magnetoelectric gel is prepared by mixing 100 parts of a solvent with a ratio of 4-6:1-2:2-4 of water:N,N-dimethylformamide:dichloromethane, and adding 0.5-2 parts of superparamagnetic ferrosoferric oxide nanoparticles, 2-8 parts of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) and 2-8 parts of sodium alginate. The bionic cartilage magnetoelectric gel utilizes N,N-dimethylformamide which is mutually soluble in deionized water and dichloromethane to neutralize their repulsive polarities, so that the hydrophilic sodium alginate sol and the hydrophobic poly (3-hydroxybutyrate-co-3-hydroxyvalerate) piezoelectric plastic are evenly mixed, and a double network semi-cross chain stacking structure is formed by cross-linking with a calcium chloride solution, so as to obtain a repair-promoting gel with composition, structure and performance that mimics cartilage, and can effectively solve the application limitations of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) in the field of cartilage tissue engineering; the invention The bionic cartilage magnetoelectric gel prepared by Mingzhong is creatively endowed with motion-driven magnetoelectric coupling cyclic conversion effect, including motion-stimulated piezoelectric response model, magnetostrictive piezoelectric response model and magnetoelectric coupling cyclic conversion effect. Under light force, it provides piezoelectric response and piezomagnetic response that can be freely excited and cyclically enhanced to induce in situ regeneration and repair of defective cartilage. Combined with Faraday's law, it releases variable electromagnetic stimulation, simulates and amplifies endogenous electromagnetic effects, cascades and regulates the expression of genes related to defective cartilage repair, and promotes in situ regeneration of hyaline cartilage tissue. It can effectively solve the disadvantages of electromagnetic field stimulation given in vitro, such as being easily weakened by tissues, uncontrollable penetration and limited quantitative intensity of action. It can also effectively solve the problem that the healing effect of traditional piezoelectric materials is limited by the inherent disadvantages of piezoelectric models. In addition, it can also effectively solve the application limitations of traditional magnetoelectric materials. The bionic cartilage magnetoelectric gel described in the present invention has a functional environment similar to that of bionic cartilage, can release electromagnetic stimulation to promote cell proliferation and migration, promote chondrocyte induction differentiation, and provide mechanical bearing and support for the repair of defective cartilage; the generated new cartilage tissue has the characteristics of transparent cartilage similar to normal cartilage tissue, which is superior to the AFe group induced by simple magnetic stimulation and the VA group induced by simple piezoelectric stimulation; the preparation method of the bionic cartilage magnetoelectric gel described in the present invention is simple and clear, the preparation conditions are easy to meet, and it is easy to achieve mass production, and it has broad market prospects in the field of cartilage tissue engineering; and the bionic cartilage magnetoelectric gel has good biocompatibility, stable piezoelectric properties, excellent piezomagnetic properties and superior magnetoelectric coupling cycle conversion ability, showing the advantages of significant healing promotion effect, multifunctional action mode, economic efficiency, simple operation, low cost, etc.; it expands the application scope of piezoelectric materials and magnetoelectric materials in the field of defective cartilage repair, and also provides a new treatment plan for accelerating defective cartilage repair and in situ regeneration of transparent cartilage.
[0134] In addition, it should be understood that although the present specification is described according to implementation modes, not every implementation mode contains only one independent technical solution. This description of the specification is only for the sake of clarity. Those skilled in the art should regard the specification as a whole. The technical solutions in each embodiment may also be appropriately combined to form other implementation modes that can be understood by those skilled in the art.
Claims
1. A double network semi-cross chain stacked bionic cartilage magnetoelectric gel, characterized in that: The bionic cartilage magnetoelectric gel is prepared by adding 0.5-2 parts of superparamagnetic ferroferric oxide nanoparticles, 2-8 parts of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) and 2-8 parts of sodium alginate into 100 parts of solvent, and the solvent is prepared from water: N,N-dimethylformamide: dichloromethane in a ratio of 4-6: 1-2: 2-4.
2. The double network semi-cross chain stacked biomimetic cartilage magnetoelectric gel according to claim 1, characterized in that: The ratio of water: N,N-dimethylformamide: dichloromethane is 6:1:
3.
3. The double network semi-cross chain stacked biomimetic cartilage magnetoelectric gel according to claim 1, characterized in that: The ratio of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) to sodium alginate in the bionic cartilage magnetoelectric gel is 1:1-3.
4. The double network semi-cross chain stacked biomimetic cartilage magnetoelectric gel according to claim 3, characterized in that: The ratio of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) to sodium alginate in the bionic cartilage magnetoelectric gel is 1:2-3.
5. The double network semi-cross chain stacked biomimetic cartilage magnetoelectric gel according to claim 1, characterized in that: The bionic cartilage magnetoelectric gel is prepared by the following method: S1. Prepare a solvent by mixing water, N,N-dimethylformamide and dichloromethane according to 4-6:1-2:2-4; S2. Take the solvent prepared in step S1, add superparamagnetic ferroferric oxide nanoparticles at a ratio of 0.5-2:100, and disperse them uniformly by ultrasonication to obtain a magnetic mixed solution; S3. Adding poly (3-hydroxybutyrate-co-3-hydroxyvalerate) to the magnetic mixed solution obtained in step S2 to obtain a superparamagnetic ferrosoferric oxide nanoparticle / poly (3-hydroxybutyrate-co-3-hydroxyvalerate) composite solution, wherein the addition ratio of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) to the solvent is 2-8:100; S4. Adding sodium alginate powder to the superparamagnetic ferroferric oxide nanoparticles / poly (3-hydroxybutyrate-co-3-hydroxyvalerate) composite solution obtained in step S3 to obtain a superparamagnetic ferroferric oxide nanoparticles / poly (3-hydroxybutyrate-co-3-hydroxyvalerate) / sodium alginate composite sol, wherein the addition ratio of sodium alginate to solvent is 2-8:100; S5. Take the superparamagnetic iron oxide nanoparticles / poly (3-hydroxybutyrate-co-3-hydroxyvalerate) / sodium alginate composite sol prepared in step S4, draw it and spread it into a mold, soak it in a calcium chloride solution for cross-linking, and then dialyze it with deionized water to obtain a double-network semi-cross-chain stacked bionic cartilage magnetoelectric gel.
6. The method for preparing the double-network semi-crossed chain stacked bionic cartilage magnetoelectric gel according to any one of claims 1 to 5, characterized in that: The steps include: S1. Prepare a solvent by mixing water, N,N-dimethylformamide and dichloromethane according to 4-6:1-2:2-4; S2. Take the solvent prepared in step S1, add superparamagnetic ferroferric oxide nanoparticles at a ratio of 0.5-2:100, and disperse them uniformly by ultrasonication to obtain a magnetic mixed solution; S3. Adding poly (3-hydroxybutyrate-co-3-hydroxyvalerate) to the magnetic mixed solution obtained in step S2 to obtain a superparamagnetic ferrosoferric oxide nanoparticle / poly (3-hydroxybutyrate-co-3-hydroxyvalerate) composite solution, wherein the addition ratio of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) to the solvent is 2-8:100; S4. Adding sodium alginate powder to the superparamagnetic ferroferric oxide nanoparticles / poly (3-hydroxybutyrate-co-3-hydroxyvalerate) composite solution obtained in step S3 to obtain a superparamagnetic ferroferric oxide nanoparticles / poly (3-hydroxybutyrate-co-3-hydroxyvalerate) / sodium alginate composite sol, wherein the addition ratio of sodium alginate to solvent is 2-8:100; S5. Take the superparamagnetic iron oxide nanoparticles / poly (3-hydroxybutyrate-co-3-hydroxyvalerate) / sodium alginate composite sol prepared in step S4, draw it and spread it into a mold, soak it in a calcium chloride solution for cross-linking, and then dialyze it with deionized water to obtain a double-network semi-cross-chain stacked bionic cartilage magnetoelectric gel.
7. The method for preparing the double network semi-cross chain stacked biomimetic cartilage magnetoelectric gel according to claim 6, characterized in that: The mass ratio of calcium chloride to deionized water in the calcium chloride solution of step S5 is 2:
100.
8. Use of the double-network semi-cross-chain stacked bionic cartilage magnetoelectric gel as claimed in claim 1 in the preparation of artificial cartilage materials.
Citation Information
Patent Citations
Method for preparing alginic acid magnetic material
CN101461945A
Composite stent and preparation method and application thereof
CN109125807A
Composite hydrogel scaffold for promoting bone-cartilage repair as well as preparation method and application of composite hydrogel scaffold
CN115607742A
Thermosensitive, biocompatible polymer carriers with changeable physical structure for therapy, diagnostics and analytics
US20070148437A1
Methods and compositions for printing biologically compatible nanotube composites of autologous tissue
US20090117087A1
Cited By
3D-printed bionic piezoelectric bracket with multifunctional gradient, preparation method and application
CN120114649A
A 3D-printed, biomimetic piezoelectric scaffold with multifunctional gradients, methods of making and uses
CN120114649B
